Neinast, Michael

Comprehensive quantification of fuel use by the failing and nonfailing human heart

Murashige, D., Jang, C., Neinast, M., Edwards, J. J., Cowan, A., Hyman, M. C., Rabinowitz, J. D., Frankel, D. S., & Arany, Z. (2020) · Science

Cardiovascular Function and Risk FactorsMetabolomics and Mass Spectrometry Studies

Cited by 580

AKT controls protein synthesis and oxidative metabolism via combined mTORC1 and FOXO1 signalling to govern muscle physiology

Jaiswal, N., Gavin, M., Loro, E., Sostre‐Colón, J., Roberson, P. A., Uehara, K., Rivera‐Fuentes, N., Neinast, M., Arany, Z., Kimball, S. R., et al. (2022) · Journal of Cachexia, Sarcopenia and Muscle

Muscle Physiology and DisordersMuscle metabolism and nutrition

Cited by 79

ERα upregulates Phd3 to ameliorate HIF-1 induced fibrosis and inflammation in adipose tissue

Kim, M., Neinast, M. D., Frank, A. P., Sun, K., Park, J., Zehr, J. A., Vishvanath, L., Morselli, E., Amelotte, M., Palmer, B. F., et al. (2014) · Molecular Metabolism

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 52

Myobolites: muscle-derived metabolites with paracrine and systemic effects

Ibrahim, A., Neinast, M., & Arany, Z. P. (2017) · Current Opinion in Pharmacology

Muscle Physiology and DisordersAdipokines, Inflammation, and Metabolic Diseases

Cited by 22